Skip to main content
Tanvex logo

Tanvex — Investor Relations & Filings

Ticker · 6541 ISIN · KYG8676P1037 TW Manufacturing
Filings indexed 32 across all filing types
Latest filing 2026-04-07 Share Issue/Capital Cha…
Country TW Taiwan
Listing TW 6541

About Tanvex

www.tanvex.com

Tanvex BioPharma, Inc. specializes in the research, development, manufacturing, and commercialization of biosimilars and innovative biologics. The company operates a vertically integrated model encompassing cell line development, process optimization, and clinical to commercial-scale production. Its portfolio focuses on biosimilars for oncology and supportive care, alongside emerging Antibody-Drug Conjugate (ADC) programs. Tanvex provides comprehensive Contract Development and Manufacturing Organization (CDMO) services, offering a unified platform that supports early-stage development through to commercial manufacturing. By maintaining GMP-compliant facilities and achieving regulatory approval for its biosimilar products, the company delivers end-to-end solutions aimed at increasing the accessibility of safe and effective treatments in international markets.

Recent filings

Filing Released Lang Actions
115年3月變更登記
Share Issue/Capital Change Classification · 85% confidence The document is a disclosure from Taiwan’s Market Observation Post System (公開資訊觀測站) provided by the listed company 泰福‐KY, detailing share capital information: par value, authorized and issued shares, capital-source breakdown, and a note on employee warrant conversion into ordinary shares. This is an announcement of a capital structure change, which fits the “Share Issue/Capital Change” category.
2026-04-07 Chinese
114年度財務比率
Fund Information / Factsheet Classification · 52% confidence The document is a standalone three‐year financial ratio analysis table “泰福‐KY最近三年度財務資料分析” provided by the company. It is not a full annual or interim report, nor an earnings release or regulatory announcement. Instead, it is a brief factsheet–style summary of key financial metrics over three years. Therefore it best fits the Fund Information / Factsheet category.
2026-03-31 Chinese

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.